000281789 001__ 281789
000281789 005__ 20251017162656.0
000281789 0247_ $$2doi$$a10.1212/WNL.0000000000214225
000281789 0247_ $$2pmid$$apmid:41100781
000281789 0247_ $$2ISSN$$a0028-3878
000281789 0247_ $$2ISSN$$a1526-632X
000281789 037__ $$aDZNE-2025-01182
000281789 041__ $$aEnglish
000281789 082__ $$a610
000281789 1001_ $$00000-0003-2420-5716$$aRohmann, Jessica L$$b0
000281789 245__ $$aEffect of Mobile Stroke Unit Dispatch on Process Parameters and Functional Outcomes in Patients With Acute Stroke: The B_PROUD-2.0 Study.
000281789 260__ $$aPhiladelphia, Pa.$$bWolters Kluwer$$c2025
000281789 3367_ $$2DRIVER$$aarticle
000281789 3367_ $$2DataCite$$aOutput Types/Journal article
000281789 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1760711042_15315
000281789 3367_ $$2BibTeX$$aARTICLE
000281789 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281789 3367_ $$00$$2EndNote$$aJournal Article
000281789 520__ $$aPrehospital stroke management on mobile stroke units (MSUs) shortens time to IV thrombolysis (IVT) and improves functional outcomes. Because IVT effects are time-dependent, optimizing workflows and dispatch-related processes may enhance MSU benefits. The B_PROUD-2.0 study aimed to determine the effect of additional MSU dispatch on functional outcomes in acute stroke patients under optimized MSU organization and service delivery.In the nonrandomized, controlled B_PROUD-2.0 study (May 2019-April 2021) conducted in Berlin, Germany, MSUs were simultaneously dispatched with conventional care ambulances for suspected stroke emergency calls, whenever available. We compared outcomes and process parameters between dispatch groups (additional MSU dispatch vs conventional care only) among patients with cerebral ischemia with disabling neurologic symptoms and no contraindications to reperfusion treatments. We used data from the Berlin dispatch center and records from the B_SPATIAL registry, consisting of 15 Berlin hospitals with stroke units. We performed pooled analyses with the B_PROUD-1.0 primary population (February 2017-April 2021) and with an extended cohort that also included patients with reperfusion treatment contraindications. The primary and co-primary outcomes were 3-month modified Rankin Scale scores (0: no deficits to 6: death) and 3-tiered disability scale scores. Effect estimates for these outcomes were obtained from ordinal logistic regressions, adjusting for a priori selected covariates after multiple imputation for missing values.Coronavirus disease 2019 pandemic and limited funding hindered full implementation of procedural improvements. A total of 1,050 patients (mean age: 74 years, 46.7% female) were included in B_PROUD-2.0 (vs 1,500 planned). We found no statistically significant effect of MSU dispatch on primary (common odds ratio [cOR] 0.90, 95% CI 0.72-1.14) or co-primary (cOR 0.86, 95% CI 0.63-1.17) outcomes in B_PROUD-2.0, and higher odds of IVT ≤1 hour of dispatch in the MSU group (OR 10.15, 95% CI 7.10-14.51). In pooled B_PROUD-1.0+2.0 primary population analyses (N = 2,666, mean age: 73 years, 46.8% female), we found a beneficial effect on primary (cOR 0.80, 95% CI 0.67-0.96) and co-primary (cOR 0.79, 95% CI 0.64-0.97) outcomes. The average effect on all stroke/TIA patients in the extended cohort (N = 4,336, mean age 75 years, 47.6% female) was also favorable (primary cOR 0.85, 95% CI 0.75-0.95; co-primary cOR 0.86, 95% CI 0.75-0.99).While we did not observe statistically significant differences in functional outcomes in the underpowered B_PROUD-2.0 study, we found beneficial effects considering both B_PROUD study periods, also when including all stroke/TIA patients.ClinicalTrials.gov: NCT03931616. Registered: April 26, 2019. First patient enrolled: May 9, 2019.The B_PROUD-2.0 study provides Class III evidence that the addition of MSUs to conventional care ambulances did not improve functional outcomes at 3 months compared with conventional care ambulances alone in patients with acute ischemic stroke.
000281789 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000281789 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000281789 650_2 $$2MeSH$$aHumans
000281789 650_2 $$2MeSH$$aFemale
000281789 650_2 $$2MeSH$$aMale
000281789 650_2 $$2MeSH$$aAged
000281789 650_2 $$2MeSH$$aMobile Health Units
000281789 650_2 $$2MeSH$$aStroke: therapy
000281789 650_2 $$2MeSH$$aThrombolytic Therapy
000281789 650_2 $$2MeSH$$aMiddle Aged
000281789 650_2 $$2MeSH$$aAged, 80 and over
000281789 650_2 $$2MeSH$$aEmergency Medical Services: methods
000281789 650_2 $$2MeSH$$aAmbulances
000281789 650_2 $$2MeSH$$aTime-to-Treatment
000281789 650_2 $$2MeSH$$aRegistries
000281789 650_2 $$2MeSH$$aTreatment Outcome
000281789 650_2 $$2MeSH$$aEmergency Medical Dispatch
000281789 650_2 $$2MeSH$$aBerlin
000281789 650_2 $$2MeSH$$aCOVID-19
000281789 7001_ $$00000-0002-1397-0060$$aPiccininni, Marco$$b1
000281789 7001_ $$00000-0002-5073-4665$$aEbinger, Martin$$b2
000281789 7001_ $$aWendt, Matthias$$b3
000281789 7001_ $$aWeber, Joachim E$$b4
000281789 7001_ $$aSchwabauer, Eugen$$b5
000281789 7001_ $$aFreitag, Erik$$b6
000281789 7001_ $$aZuber, Martina$$b7
000281789 7001_ $$aBernhardt, Lydia$$b8
000281789 7001_ $$aLange, Julia$$b9
000281789 7001_ $$aErdur, Hebun$$b10
000281789 7001_ $$aBehrens, Janina$$b11
000281789 7001_ $$00000-0003-4043-1115$$aGaneshan, Ramanan$$b12
000281789 7001_ $$00000-0003-4165-2366$$aSchlemm, Ludwig$$b13
000281789 7001_ $$aHarmel, Peter$$b14
000281789 7001_ $$0P:(DE-2719)9000189$$aLiman, Thomas G.$$b15$$udzne
000281789 7001_ $$aLorenz-Meyer, Irina$$b16
000281789 7001_ $$aRohrpasser-Napierkowski, Ira$$b17
000281789 7001_ $$aHille, Annegret$$b18
000281789 7001_ $$aBohner, Georg$$b19
000281789 7001_ $$aNabavi, Darius G$$b20
000281789 7001_ $$aSchmehl, Ingo$$b21
000281789 7001_ $$aEkkernkamp, Axel$$b22
000281789 7001_ $$aJungehulsing, Gerhard J$$b23
000281789 7001_ $$aMackert, Bruno-Marcel$$b24
000281789 7001_ $$aHartmann, Andreas$$b25
000281789 7001_ $$0P:(DE-2719)2811033$$aEndres, Matthias$$b26
000281789 7001_ $$00000-0002-4785-0366$$aAudebert, Heinrich J$$b27
000281789 773__ $$0PERI:(DE-600)1491874-2$$a10.1212/WNL.0000000000214225$$gVol. 105, no. 9, p. e214225$$n9$$pe214225$$tNeurology$$v105$$x0028-3878$$y2025
000281789 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9000189$$aExternal Institute$$b15$$kExtern
000281789 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811033$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b26$$kDZNE
000281789 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000281789 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz$$d2025-01-02$$wger
000281789 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROLOGY : 2022$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-02
000281789 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEUROLOGY : 2022$$d2025-01-02
000281789 9201_ $$0I:(DE-2719)1811005$$kAG Endres$$lInterdisciplinary Dementia Research$$x0
000281789 980__ $$ajournal
000281789 980__ $$aEDITORS
000281789 980__ $$aVDBINPRINT
000281789 980__ $$aI:(DE-2719)1811005
000281789 980__ $$aUNRESTRICTED